Becton Dickinson (BDX): Evaluating Valuation After New Immunology Partnership with University of Pennsylvania [Yahoo! Finance]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Yahoo! Finance
Immune Health to build advanced flow cytometry panels and run a 1,000 patient immune profiling study. See our latest analysis for Becton Dickinson. Those immune profiling and diagnostics wins come as investors are still cautious, with the share price at $195.67 and a year to date share price return of minus 13.61 percent, while the one year total shareholder return of minus 11.92 percent and three year total shareholder return of minus 19.17 percent suggest momentum has been fading despite steady revenue and earnings growth. If this kind of healthcare innovation is on your radar, it could be worth exploring other opportunities across healthcare stocks to see which names are building similar long term momentum. With shares lagging over one and three years despite mid single digit revenue growth, stronger earnings and a hefty implied intrinsic discount, is Becton Dickinson now a mispriced compounding story, or is the market already discounting years of future growth? With Bect
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- ???????????????????????????????????????????????2033????403??????????????(CAGR)6.03%??????????? [CNET News]CNET News
- Becton, Dickinson accused of hindering competition in hernia mesh market [Seeking Alpha]Seeking Alpha
- ??BD?????????????????????????????Science Connect Program???? [CNET News]CNET News
- BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow CytometryPR Newswire
- Becton, Dickinson and Company (NYSE:BDX) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.MarketBeat
BDX
Earnings
- 11/6/25 - Beat
BDX
Sec Filings
- 12/18/25 - Form ARS
- 12/18/25 - Form DEFA14A
- 12/18/25 - Form DEF
- BDX's page on the SEC website